Efficacy of lamivudine in the treatment of children with chronic hepatitis B

Hepatology Research

Volumn 31, Issue 4, 2005, Pages 217-222

  Figlerowicz, Magdalena ^a   Kowala Piaskowska, Arleta ^a   Filipowicz, Marlena ^a   Bujnowska, Agnieszka ^a   Mozer Lisewska, Iwona ^a   Słuzewski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Children; Hepatitis B virus; Lamivudine therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; INTERFERON; LAMIVUDINE;

ADOLESCENT; ANTIVIRAL ACTIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; ENZYME ACTIVITY; FATIGUE; FEMALE; HEADACHE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; POLAND; PRIORITY JOURNAL; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; STOMACH PAIN; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIREMIA; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 19444367679     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.02.003     Document Type: Article

References (25)

1. W.M. Lee Hepatitis B virus infection N Engl J Med 1997 337-1733
2. H.S. Conjeevaram A. Suk-Fong Lok Management of chronic hepatitis B J Hepatol 38 2003 S90-S103
3. W. Szumness E.J. Harley A.M. Prince Intrafamilial spread of asymptomatic hepatitis B Am J Med Sci 270 1975 293-304
4. H.J. Alter You'll wonder where the yellow went: A 15-year retrospective of post-transfusion hepatitis In: S.B. Moore editor. Transfusion-transmitted Viral Diseases 1987 American Association of Blood Banks Arlington, VA 53-86
5. F.B. Hollinger Hepatitis B virus In: B.N. Fields P.M. Knipe P.M. Howley et al., editors. Fields Virology 3rd ed. 1996 Lippincott-Raven Publishers Philadelphia 2739-2807
6. A. Derso E.H. Boxall M.J. Tarlow T.H. Flewwett Transmission of HBsAg from mother to infant in four ethnic groups Br Med J 1 1978 949-952
7. V.C.W. Wong H.W. Reesink H.M.H Ip P.N. Lelie et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin Lancet 1 1984 921-926
8. R.P. Beasley Lee GCY C.H. Roan L.Y. Hwang et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine Lancet ii 1983 1099-1102
9. N.C. Tassopoulos G.J. Papaevangelou M.H. Sjogren A. Roumeliotou-Karayannis Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults Gastroenterology 92 1987 1844-1850
10. S. Sherlock R.A. Fox S.P. Niazi P.J. Scheuer Chronic liver disease and primary liver cell cancer with hepatitis-associated (Australia) antigen in serum Lancet 1 1970 1243-1247
11. P. Maupas J.L. Melnick Hepatitis B infection and primary liver cancer Prog Med Virol 27 1981 1-5
12. W. Sluzewski A. Gladysz Consensus of Polish pediatric hepatology group concerning treatment of chronic hepatitis B in children Ped Prakt 9 2001 37-39
13. M. Figlerowicz M. Alejska A. Kurzyńska-Kokorniak M. Figlerowicz Genetic variability: The key problem in the prevention and therapy of RNA-based virus infections Med Res Rev 23 2003 488-518
14. C.L. Lai R.N. Chien N.W. Leung T.T. Chang et al. A one-year trial of lamivudine for chronic hepatitis B N Engl J Med 1998 339-361
15. J.L. Dienstag E.R. Schiff T.L. Wright R.P. Perrillo et al. Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256
16. S.W. Schalm J. Heathcote J. Cianciara G. Farrel Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial Gut 46 2000 562
17. Y.F. Liaw N.W. Leung T.T. Chang R. Guan et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group Gastroenterology 2000 119-172
18. N.W. Leung C.L. Lai T.T. Chang R. Guan et al. On behalf of the Asia Hepatitis Lamivudine Study Group Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy Hepatology 33 2001 1527
19. M.M. Jonas D.A. Kelly J. Mizerski I.B. Badia et al. Clinical trial of lamivudine In children with chronic hepatitis B N Eng J Med 346 2002 1706
20. R.N. Chien Y.F. Liaw M. Atkins For Asian Hepatitis Lamivudine Trial Group Pretherapy alanine transaminase level as a determinant for hepatitis e antigen seroconversion during lamivudine treatment for chronic hepatitis B Hepatology 30 1999 770
21. R.P. Perrillo C.L. Lai Y.F. Liaw J.L. Dienstag et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B Hepatology 36 2002 186
22. S. Ohkoshi N. Ogata T. Ichida The long-term clinical outcome of 1-year treatment of chronic hepatitis B with lamivudine-5 years observation Hepatol Res 27 1 2003 13-17
23. R. Guan C.L. Lai Y.F. Liaw S.G. Lim C.M. Lee Efficacy and safety of 5 years lamivudine treatment of Chinese patients with chronic hepatitis B J Gastroenterol Hepatol A60 Suppl. 1 2001 187
24. Y.F. Liaw Results of lamivudine in Asian trials In: Proceedings of EASL International Consensus Conference on Hepatitis B 2002
25. M. Kohmoto M. Enomoto Y. Yano S. Otani et al. Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: Comparison with three other assays Hepatol Res 26 2 2003 125-133